Report - authorised longer - European Medicines Agency · patients with hepatic impairment (see section 5.2). Paediatric population The safety and efficacy of Eperzan in children and adolescents

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form